Trans Canada Gold Advances Phase 2-Drilling at the Harrison Lake District Scale Gold Project and Awaits PhotonAssay Results From Phase 1-Drilling Nov 3, 2026 04:45PM

VANCOUVER, BC / ACCESS Newswire / November 3, 2026 / Trans Canada Gold Corp. (TSXV: TTG)(OTCQB: TTGXF) ("Trans Canada" or the "Company"), is pleased to announce that the Company has successfully completed its most recent financing raising over $2.2 million dollars required to advance Phase-2 underground drilling and proposed exploration work on Bear Mountain at the Harrison Lake Gold Project located in Southwestern B.C. The Company intends to use approximately... (continue reading...)


Heart Failure Pipeline 2026: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Abbott, Berlin Heart GmbH, Biotronik, Boston Scientific Corp, Jarvik Heart Inc Nov 3, 2026 04:45PM (Albany, New York) - November 03, 2026: As per DelveInsight’s assessment, globally, Heart Failure pipeline constitutes 70+ key companies continuously working towards developing 75+ Heart Failure treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

“Heart Failure Pipeline Insight, 2026" report by DelveInsight outlines comprehensive insights into the present clinical development... (continue reading...)


22q11.2 Deletion Syndrome Market Size in the 7MM is projected to grow at a significant CAGR over the forecast period of 2026-2036 | DelveInsight Nov 3, 2026 04:45PM The Key 22q11.2 Deletion Syndrome Companies in the market include – Sumitomo Pharma, Enzyvant, Roivant Sciences, Zynerba Pharmaceuticals, Harmony Biosciences, Nobias Therapeutics, and others.

(Albany, US), November 3, 2026 - DelveInsight's '22q11.2 Deletion Syndrome Market Insights, Epidemiology and Market Forecast – 2036' report delivers an in-depth understanding of 22q11.2 Deletion Syndrome, historical and forecasted epidemiology, as well as the 22q11.2 deletion... (continue reading...)


Frontotemporal Dementia Market Size in the 7MM is projected to grow at a ~15% CAGR over the forecast period of 2026-2036 | DelveInsight Nov 3, 2026 04:45PM The Key Frontotemporal Dementia Companies in the market include – Passage Bio, Denali Therapeutics, Vesper Bio, AviadoBio, Transposon Therapeutics, Alector, and others.

(Albany, US), November 03, 2026 - DelveInsight's 'Frontotemporal Dementia (FTD) – Market Insights, Epidemiology and Market Forecast – 2036' report delivers an in-depth understanding of Frontotemporal Dementia, historical and forecasted epidemiology, as well as the Frontotemporal Dementia market trends in... (continue reading...)


Hypercholesterolemia Market Projected to Achieve Substantial Growth by 2036, Led by Key Companies and Strategic Developments | Novartis, Esperion Therapeutics, Esperion Therapeutics, EPIC BIO, Amytrx Nov 3, 2026 04:45PM The Key Hypercholesterolemia Companies in the market include - Novartis, Esperion Therapeutics, Esperion Therapeutics, EPIC BIO, Amytrx Therapeutics, Chroma Medicine, Verve Therapeutics, Inc, Vaxxinity, Inc, Arrowhead Pharmaceuticals, Merck Sharp & Dohme LLC, Haisco Pharmaceutical Group Co., Ltd., Akeso Biopharma, Addpharma Inc., Jiangsu HengRui Medicine Co., Ltd., and others.

(Albany, New York) - November 03, 2026: DelveInsight’s “Hypercholesterolemia Market Insights,... (continue reading...)


More Press Releases

View Older Stories

Nov 3, 2026 04:45PM Metastatic HR+/HER2− Breast Cancer Market Size in the 7MM is projected to grow at a significant CAGR over the forecast period of 2026-2036 | DelveInsight
Nov 3, 2026 04:45PM Concentrix Announces Chief Financial Officer Succession
Nov 3, 2026 04:45PM Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 3, 2026 04:45PM Innospec REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
Nov 3, 2026 04:44PM First Industrial Declares Common Stock Dividends
Nov 3, 2026 04:43PM 60 Seconds to Sellout: How Maureen Kelly Built tarte's Fastest-Selling Collab alongside Roller Rabbit
Nov 3, 2026 04:44PM TVS Breaks New Ground at EICMA 2026 With Everyday Urban Sportsbike RTR 125 LC
Nov 3, 2026 04:43PM Western Forest Products and Tla’amin Nation Complete Sale of Stillwater Forest Operation
Nov 3, 2026 04:40PM ReeXploration Announces Effective Date of Five-for-One Share Consolidation
Nov 3, 2026 04:40PM ILC Dover Agrees to Pay Record High $13 Million to Settle Cybersecurity False Claims Act Case Brought by Whistleblower Law Collaborative Client
Nov 3, 2026 04:40PM MediWound Announces $15 Million Bought Deal Offering of Ordinary Shares
Nov 3, 2026 04:40PM Gastric Cancer Market to Expand Rapidly by 2035 Amid Increasing Investments and Innovation | AstraZeneca, Daiichi Sankyo, Bristol-Myers Squibb, Amgen, Jazz Pharma, BeiGene, Zymeworks, ALX Oncology
Nov 3, 2026 04:40PM Cutaneous Lupus Erythematosus Pipeline Analysis 2026: Phase III and Phase II Assets, MOA Breakdown, and ROA Trends | Biogen, Horizon Therapeutics, Bristol–Myers Squibb, AstraZeneca, Sanofi, Amgen
Nov 3, 2026 04:40PM Mantle Cell Lymphoma Clinical Trial Pipeline Gains Momentum: 45+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
Nov 3, 2026 04:40PM What’s Fueling the Ovarian Cancer Market Boom? Industry to Cross USD 5.7 Billion by 2034 | pharma& GmbH, GlaxoSmithKline, Verastem Oncology, Daiichi Sankyo, AstraZeneca, ProfoundBio, Genmab, Tesaro
Nov 3, 2026 04:39PM One World Chain Launches EVM-Compatible Layer 1 Blockchain and Activates Native OWCT Asset
Nov 3, 2026 04:39PM Kadant Reports Third Quarter 2026 Results
Nov 3, 2026 04:38PM MotorWeek announces streaming deal with DRIVEN
Nov 3, 2026 04:35PM Glucagon-Like Peptide Agonist Clinical Trial Pipeline Gains Momentum: 45+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
Nov 3, 2026 04:35PM AM Best Revises Outlooks to Positive for Funeral Directors Life Insurance Company
Nov 3, 2026 04:33PM JELD-WEN Reports Third Quarter 2026 Results
Nov 3, 2026 04:33PM Toufayan Bakeries Introduces "Simply Sourdough Pita"
Nov 3, 2026 04:31PM IGT and MGM Springfield Launch First Wide-Area Progressive Jackpot Games in Massachusetts
Nov 3, 2026 04:30PM Amdocs Limited Reports Fourth Quarter Fiscal 2026 Results & Full Year Fiscal 2026 Results
Nov 3, 2026 04:30PM Synovial Sarcoma Market and Pipeline Appear Robust With Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
Nov 3, 2026 04:30PM Anterior Cruciate Ligament Injuries Market and Pipeline Appear Robust With Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
Nov 3, 2026 04:30PM Post-Traumatic Stress Disorder Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
Nov 3, 2026 04:30PM Autism Spectrum Disorder Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
Nov 3, 2026 04:30PM Radiotherapy Induced Oral Mucositis Market and Pipeline Appear Robust With Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
Nov 3, 2026 04:30PM NCLA Asks Court to End WA Dept. of Fish and Wildlife’s Illegal 24-Hour Surveillance of Crab Boats
Nov 3, 2026 04:30PM Bristow Group Reports Third Quarter 2026 Results
Nov 3, 2026 04:30PM Intrepid Announces Third Quarter 2026 Results
Nov 3, 2026 04:30PM Dauch Corporation Announces Employee Inducement Award Under NYSE Rule 303A.08
Nov 3, 2026 04:30PM Viking Therapeutics to Participate at Upcoming Investor Conferences
Nov 3, 2026 04:30PM Tronox Declares Fourth Quarter 2026 Dividend
Nov 3, 2026 04:30PM GeoPark Reports Third Quarter 2026 Results
Nov 3, 2026 04:30PM Vanda Pharmaceuticals Announces Participation at November 2026 Investor Conferences
Nov 3, 2026 04:30PM Everus Reports Third Quarter 2026 Results, Raises 2026 Guidance
Nov 3, 2026 04:30PM Hormel Foods Corporation Announces Fourth Quarter Earnings Call
Nov 3, 2026 04:30PM Limbach Reports Third Quarter 2026 Results
Nov 3, 2026 04:30PM SUMMIT HOTEL PROPERTIES REPORTS THIRD QUARTER 2026 RESULTS
Nov 3, 2026 04:30PM WhiteFiber Completes Acquisition of Two North Carolina Data Center Development Sites and Provides NC-1 Update
Nov 3, 2026 04:30PM Solstice Advanced Materials Declares Dividend of $0.075 per Common Share
Nov 3, 2026 04:30PM Verra Mobility Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Nov 3, 2026 04:30PM X4 Pharmaceuticals to Participate in Guggenheim, Stifel, and Jefferies Conferences in November 2026
Nov 3, 2026 04:30PM XMax Inc. Announces Preliminary Third Quarter 2026 Financial Results
Nov 3, 2026 04:30PM Kevin Sayer Joins Guardant Health Board of Directors
Nov 3, 2026 04:30PM Melcor Developments announces third quarter results, declares quarterly dividend of $0.15 per share
Nov 3, 2026 04:30PM State Street Corporation (NYSE: STT) Announces 2027 Quarterly Financial Results Release Dates
Nov 3, 2026 04:30PM VSE Corporation Declares Quarterly Cash Dividend
View Older Stories